Services
-
Phase I/IIa
5/17/2011
You need to safely advance your drug candidate through phase I/IIa. The key to achieving this objective — on time — is to focus on maximizing critical data through strategic study design.
-
Medical Monitoring
Addressing the clinical implications of research
Rho’s Medical Monitors come from life science careers, including experience in medical and academic institutions. Our experts have both clinical and research experience, and some serve as academic investigators. They are able to apply their practical knowledge and experience to present solutions for the issues that occur in clinical trials and research studies.